1. Home
  2. MBIO vs IMTE Comparison

MBIO vs IMTE Comparison

Compare MBIO & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • IMTE
  • Stock Information
  • Founded
  • MBIO 2015
  • IMTE 2008
  • Country
  • MBIO United States
  • IMTE Malaysia
  • Employees
  • MBIO N/A
  • IMTE N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • IMTE Consumer Electronics/Appliances
  • Sector
  • MBIO Health Care
  • IMTE Consumer Staples
  • Exchange
  • MBIO Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • MBIO 4.7M
  • IMTE 4.1M
  • IPO Year
  • MBIO N/A
  • IMTE N/A
  • Fundamental
  • Price
  • MBIO $1.24
  • IMTE $1.08
  • Analyst Decision
  • MBIO
  • IMTE
  • Analyst Count
  • MBIO 0
  • IMTE 0
  • Target Price
  • MBIO N/A
  • IMTE N/A
  • AVG Volume (30 Days)
  • MBIO 1.6M
  • IMTE 58.5K
  • Earning Date
  • MBIO 08-12-2025
  • IMTE 07-15-2025
  • Dividend Yield
  • MBIO N/A
  • IMTE N/A
  • EPS Growth
  • MBIO N/A
  • IMTE N/A
  • EPS
  • MBIO N/A
  • IMTE N/A
  • Revenue
  • MBIO N/A
  • IMTE $123,337.00
  • Revenue This Year
  • MBIO N/A
  • IMTE N/A
  • Revenue Next Year
  • MBIO N/A
  • IMTE N/A
  • P/E Ratio
  • MBIO N/A
  • IMTE N/A
  • Revenue Growth
  • MBIO N/A
  • IMTE 4.75
  • 52 Week Low
  • MBIO $0.89
  • IMTE $0.51
  • 52 Week High
  • MBIO $31.00
  • IMTE $3.17
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 50.75
  • IMTE 50.37
  • Support Level
  • MBIO $0.89
  • IMTE $0.74
  • Resistance Level
  • MBIO $2.13
  • IMTE $1.03
  • Average True Range (ATR)
  • MBIO 0.16
  • IMTE 0.09
  • MACD
  • MBIO 0.04
  • IMTE 0.00
  • Stochastic Oscillator
  • MBIO 28.05
  • IMTE 74.92

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: